Retrovirus isolated from mantle histiocytes in mantle cell lymphoma
CA 2454879 A1 · Owner: Herndier, Brian · Inventors: Mcgrath, Michael S.; Herndier, Brian
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention features an isolated intact virus associated with human , lymphoma and originally isolated from a mantle cell lymphoma referred to , herein as a mantle histiocyte retrovirus (MHRV). The invention also features compositions and methods for detecting MHRV as well as methods and , compositions for propagating MHRV in vitro screening for anti-MHRV agents, and generation of attenuated MHRV strains.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 15, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 15, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 15, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.